News

08 Nov 2017

REPROCELL Chooses Science Exchange as the Preferred Partner to Increase Accessibility of its Predictive Drug Discovery Services

Press release: REPROCELL Chooses Science Exchange as the Preferred Partner to Increase Accessibility of its Predictive Drug Discovery Services
Read More >>

08 Nov 2017

Visit REPROCELL at the “North East England Life Science Showcase” in Cambridge, MA (USA) on November 30, 2017

Visit REPROCELL at the “North East England Life Science Showcase” in Cambridge, MA (USA) on November 30, 2017
Read More >>

07 Nov 2017

Prof Stefan Przyborski to chair and speak at SMi Group’s 3D Cell Culture 2018 Conference

REPROCELL Europe Ltd's CSO Prof Stefan Przyborski to chair and speak at SMi Group’s 3D Cell Culture 2018 Conference
Read More >>

27 Sep 2017

Article by Dr David Bunton (co-authored) in the European Pharmaceutical Review, Autumn 2017

REPROCELL Europe Ltd’s CEO, Dr David Bunton, has co-authored an article titled New Strategy that has been published in the European Pharmaceutical Review, Autumn 2017. The article is in the EPR’s section, Applied Research, Development and Production. It is co-authored by David Bunton at REPROCELL Europe, Marian McNeil at Stratified Medicine Scotland and Pamela Brankin at Aridhia.
Read More >>

1 2 3 4 >>

Visit REPROCELL at the “North East England Life Science Showcase” in Cambridge, MA (USA) on November 30, 2017

08/11/2017

For life scientists in the USA, the North East England Life Science Showcase will be held on Thursday, November 30th, 2017 at the Boston Mariott Hotel in Cambridge, MA.

 

View the program and sign up here.

 

The orgainzer of the North East England Life Science Showcase, Prof. Anne Dickinson, Director of Alcyomics, will be giving a showcase presentation titled In vitro pre-clinical testing for predicting adverse immune reactions. Alcyomics’ pre-clinical Skimune®3D service uses REPROCELL’s Alvetex in its non-artificial human skin explants for safety and efficacy assessment of novel compounds and drugs.

 

Also included in the event program is a showcase presentation by REPROCELL’s Senior Technical Product Manager, Robert Annand, PhD. Dr Annand’s presentation on Human Tissue and 3D-Cell based Models for Drug Discovery will showcase REPROCELL’s pre-clinical contract research organization provides unique custom pharmacology assay services using freshly-sourced human tissues and 3D tissue models.

 

REPROCELL Europe Ltd.’s operations are based in North East England and in nearby Scotland. Our CSO, Prof. Stefan Przyborski, is also Professor of Cell Technology at Durham University (in North East England). Our CEO, Dr David Bunton, an expert in vascular pharmacology, was co-founder of Biopta (now REPROCELL Europe’s Center for Predictive Drug Discovery in Glasgow, Scotland) which specializes in drug discovery contract research using ethically sourced live human tissue from a network of hospitals.

 

The event is free to attend. View the program and sign up here. Please register by Friday, November 17th.

Live chat by BoldChat